Find uplifting stories about heroes, innovations, and solutions
1034 results for "ebola vaccine"
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
A $60 million global health initiative is rushing three new vaccine candidates to combat a deadly Ebola outbreak in the Democratic Republic of Congo. The same mRNA technology that helped end the COVID-19 pandemic could now save lives in Central Africa.
Three promising vaccine candidates just received $60 million in emergency funding to combat the Bundibugyo Ebola strain spreading in Central Africa. For the first time, doctors will also test a prevention pill that could stop the disease before it starts.
Scientists are fast-tracking three promising vaccines to fight a rare Ebola species that's killed nearly 250 people in Central Africa. Using lessons from COVID, researchers say they're working with urgency to protect communities before the outbreak grows worse.
A deadly disease that once terrorized West Africa is about to get much easier to stop. A new $30 million project will make the Ebola vaccine cheaper and possible to store in regular refrigerators, bringing lifesaving protection to remote communities across Africa.
A new partnership aims to make the Ebola vaccine storable in regular refrigerators instead of ultra-cold freezers, solving a major problem for remote African communities. The $30 million project could also cut costs dramatically and increase production during outbreaks.
Liberia is getting ready to vaccinate healthcare workers at its borders and ports of entry against Ebola, strengthening defenses after learning hard lessons from past outbreaks. The move protects those on the frontlines while the country watches a neighboring outbreak closely.
Global health leaders just unlocked $62 million to speed three promising Ebola vaccines toward trials as Central Africa battles a dangerous outbreak. The coordinated push brings hope for containing the current crisis and preventing future ones.
In a powerful sign of hope during a challenging outbreak, five people have recovered from a rare form of Ebola that has no approved treatment or vaccine. Their survival offers encouragement to communities facing the virus in the Democratic Republic of Congo.
The World Health Organization just identified three promising experimental treatments for a challenging Ebola strain, bringing hope to affected communities in Central Africa. Multiple vaccines are also moving toward trials within months.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Fc1%2F6a%2Fc16ac6d5-f437-4c71-9c41-7399ad528794%2Febola-outbreak.jpg)
Health experts have identified several experimental treatments and vaccines that could help slow a deadly Ebola outbreak in Congo and Uganda. A repurposed COVID-19 pill shows particular promise in preventing the disease after exposure.
As Eastern Congo battles a deadly Ebola outbreak without a vaccine, the country's top virus expert says existing treatments and proven strategies offer real hope. Dr. Jean-Jacques Muyembe, who helped discover Ebola in 1976, is leading the charge to adapt successful methods from past epidemics.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
What looked like a massive Ebola outbreak in Congo just got much smaller. Better testing revealed that over 1,000 suspected cases were actually just 116, and five people have already recovered.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Showing 20 of 1034